MENU
+Compare
JAZZ
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$136.01
Change
-$0.64 (-0.47%)
Capitalization
8.22B

JAZZ Jazz Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for JAZZ with price predictions
Feb 21, 2025

JAZZ in upward trend: 10-day moving average crossed above 50-day moving average on January 29, 2025

The 10-day moving average for JAZZ crossed bullishly above the 50-day moving average on January 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 11, 2025. You may want to consider a long position or call options on JAZZ as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for JAZZ just turned positive on February 11, 2025. Looking at past instances where JAZZ's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

JAZZ moved above its 50-day moving average on February 10, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JAZZ advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 226 cases where JAZZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JAZZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

JAZZ broke above its upper Bollinger Band on February 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JAZZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.971) is normal, around the industry mean (12.481). P/E Ratio (19.265) is within average values for comparable stocks, (84.012). Projected Growth (PEG Ratio) (0.919) is also within normal values, averaging (1.602). JAZZ has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (2.318) is also within normal values, averaging (250.738).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JAZZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

JAZZ is expected to report earnings to fall 12.41% to $5.79 per share on February 25

Jazz Pharmaceuticals plc JAZZ Stock Earnings Reports
Q4'24
Est.
$5.79
Q3'24
Beat
by $1.11
Q2'24
Beat
by $0.53
Q1'24
Missed
by $1.50
Q4'23
Missed
by $0.16
The last earnings report on November 06 showed earnings per share of $6.61, beating the estimate of $5.50. With 575.54K shares outstanding, the current market capitalization sits at 8.22B.
A.I. Advisor
published General Information

General Information

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Waterloo Road
Phone
+353 16347800
Employees
2800
Web
https://www.jazzpharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL245.55-0.28
-0.11%
Apple
BTC.X96258.000000-319.757800
-0.33%
Bitcoin cryptocurrency
SPY599.94-10.44
-1.71%
SPDR® S&P 500® ETF Trust
GME26.42-0.62
-2.29%
GameStop Corp
TSLA337.80-16.60
-4.68%
Tesla

JAZZ and Stocks

Correlation & Price change

A.I.dvisor tells us that JAZZ and RPRX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JAZZ and RPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+1.07%
RPRX - JAZZ
33%
Poorly correlated
+1.51%
DNA - JAZZ
32%
Poorly correlated
-6.52%
ATRA - JAZZ
31%
Poorly correlated
-5.94%
JBPHF - JAZZ
30%
Poorly correlated
N/A
QURE - JAZZ
29%
Poorly correlated
-6.56%
More